Human mast cells release the migraine-inducing factor pituitary adenylate cyclase-activating polypeptide (PACAP).

Autor: Okragly AJ; 1 Immunology Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA., Morin SM; 2 Neuroscience Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA., DeRosa D; 1 Immunology Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA., Martin AP; 1 Immunology Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA., Johnson KW; 2 Neuroscience Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA., Johnson MP; 2 Neuroscience Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA., Benschop RJ; 1 Immunology Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.
Jazyk: angličtina
Zdroj: Cephalalgia : an international journal of headache [Cephalalgia] 2018 Aug; Vol. 38 (9), pp. 1564-1574. Date of Electronic Publication: 2017 Nov 05.
DOI: 10.1177/0333102417740563
Abstrakt: Background Many patients with migraines suffer from allergies and vice versa, suggesting a relationship between biological mechanisms of allergy and migraine. It was proposed many years ago that mast cells may be involved in the pathophysiology of migraines. We set out to investigate the relationship between mast cell activation and known neurogenic peptides related to migraine. Methods Cultured human mast cells were assayed for the presence of neuropeptides and their receptors at the RNA and protein level. Immunohistochemistry analyses were performed on tissue resident and cultured mast cells. Mast cell degranulation assays were performed and pituitary adenylate cyclase-activating polypeptide (PACAP) activity was measured with a bioassay. Results We found that cultured and tissue resident human mast cells contain PACAP in cytoplasmic granules. No other neurogenic peptide known to be involved in migraine was detected, nor did mast cells express the receptors for PACAP or other neurogenic peptides. Furthermore, mast cell degranulation through classic IgE-mediated allergic mechanisms led to the release of PACAP. The PACAP released from mast cells was biologically active, as demonstrated using PACAP receptor reporter cell lines. We confirmed existing literature that mast cell degranulation can also be induced by several neurogenic peptides, which also resulted in PACAP release. Conclusion Our data provides a potential biological explanation for the association between allergy and migraine by demonstrating the release of biologically active PACAP from mast cells.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje